ImmuPharma Share Price Prediction (2025–2030): Expert Analysis & Predictions
Jun 7, 2025 | By Team SR

As investors look to capitalize on emerging biotech opportunities, ImmuPharma has gained attention for its pioneering peptide-based therapies. With its listing on the London Stock Exchange and a steady focus on innovative biopharmaceutical development, many are searching for the ImmuPharma share price forecast for both the near and long term.
In this comprehensive analysis, we break down the ImmuPharma share price prediction from 2025 to 2030. Whether you're looking for the ImmuPharma share price forecast today UK, planning for tomorrow, or thinking long-term, this post provides expert-driven insights supported by current data.
About ImmuPharma
ImmuPharma PLC is a biopharmaceutical company focused on the research and development of peptide-based therapeutics. Peptides are naturally occurring molecules that occupy a unique space between small molecule drugs and large proteins, making them promising candidates for treating a wide range of conditions. The company's flagship drug, Lupuzor, targets autoimmune diseases like lupus and has been a focal point of its R&D efforts.
ImmuPharma Share Price Overview (Today)
As of the latest data:
- Current Price: 2.675 GBX
- Previous Close: 2.675 GBX
- Change: 0.00 (0.00%)
- Volume: 0
- Open / High / Low / Bid / Ask: All static at 0.00 GBX
While the trading is flat today, the long-term potential lies in clinical trial success, FDA/EMA approvals, and licensing deals.
ImmuPharma Share Price Forecast 2025
Month | Forecast Price (GBX) |
January | 2.78 |
February | 2.84 |
March | 2.90 |
April | 3.01 |
May | 3.08 |
June | 3.15 |
July | 3.21 |
August | 3.32 |
September | 3.40 |
October | 3.52 |
November | 3.60 |
December | 3.75 |
ImmuPharma Share Price Forecast 2026
Month | Forecast Price (GBX) |
January | 3.80 |
February | 3.90 |
March | 4.02 |
April | 4.15 |
May | 4.25 |
June | 4.38 |
July | 4.52 |
August | 4.60 |
September | 4.74 |
October | 4.85 |
November | 4.96 |
December | 5.10 |
ImmuPharma Share Price Forecast 2027
Month | Forecast Price (GBX) |
January | 5.20 |
February | 5.35 |
March | 5.45 |
April | 5.58 |
May | 5.72 |
June | 5.88 |
July | 6.01 |
August | 6.15 |
September | 6.28 |
October | 6.40 |
November | 6.56 |
December | 6.70 |
RECOMMENDED FOR YOU

Alba Mineral Resources Share Price Prediction (2025–2030): Expert Analysis & Predictions
Kailee Rainse
Apr 10, 2025

Petrofac Share Price Prediction (2025-2030): Expert Analysis & Predictions
Kailee Rainse
Mar 29, 2025
ImmuPharma Share Price Forecast 2028
Month | Forecast Price (GBX) |
January | 6.85 |
February | 7.00 |
March | 7.18 |
April | 7.32 |
May | 7.45 |
June | 7.60 |
July | 7.74 |
August | 7.88 |
September | 8.00 |
October | 8.12 |
November | 8.28 |
December | 8.40 |
ImmuPharma Share Price Forecast 2029
Month | Forecast Price (GBX) |
January | 8.55 |
February | 8.70 |
March | 8.85 |
April | 9.00 |
May | 9.18 |
June | 9.30 |
July | 9.45 |
August | 9.60 |
September | 9.75 |
October | 9.90 |
November | 10.05 |
December | 10.20 |
ImmuPharma Share Price Forecast 2030
Month | Forecast Price (GBX) |
January | 10.35 |
February | 10.52 |
March | 10.68 |
April | 10.85 |
May | 11.02 |
June | 11.18 |
July | 11.35 |
August | 11.50 |
September | 11.66 |
October | 11.80 |
November | 11.95 |
December | 12.10 |
Conclusion - ImmuPharma Share Price
The ImmuPharma share price forecast UK shows promising signs of growth through 2030. From a modest rise in 2025 to a potential quadrupling by 2030, much depends on regulatory outcomes and clinical milestones. The ImmuPharma share price forecast today UK may not yet reflect its long-term trajectory, but investors seeking biotech exposure could see strong returns.
Stay updated on the ImmuPharma share price forecast tomorrow and watch for developments in pipeline drugs that could impact valuation.
FAQs: ImmuPharma Share Price Forecast
What is the ImmuPharma share price forecast for 2025?
Is ImmuPharma a good long-term investment?
What is the ImmuPharma share price forecast UK for tomorrow?
How does ImmuPharma’s peptide focus influence its share price?
Explore more:-
Disclaimer:
- The information is based on our understanding of the stock's historical performance.
- Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
- The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
- For further inquiries about the stock market, please contact us via email.